Transdermal progesterone creams for postmenopausal women: More hype than hope?

Medical Journal of Australia

Volumn 182, Issue 5, 2005, Pages 237-239

  Wren, Barry G ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DIETHYLSTILBESTROL; ESTROGEN; LIPID; PROGESTERONE;

ARTICLE; BONE METABOLISM; CLINICAL TRIAL; CREAM; DRUG EFFICACY; DRUG MECHANISM; DRUG SOLUBILITY; DRUG TISSUE LEVEL; DRUG TRANSPORT; ENDOMETRIUM CANCER; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPHILICITY; MENOPAUSAL SYNDROME; MOOD DISORDER; PEER REVIEW; PROGESTERONE BLOOD LEVEL; PSYCHOSEXUAL DISORDER; SALIVA LEVEL; SYMPTOMATOLOGY; VASOMOTOR REFLEX;

EID: 14844358972     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06676.x     Document Type: Article

References (32)

1. Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-333.
2. Smith DC, Prentice R, Thompson DJ, Herrman WL. Association of exogenous estrogens and endometrial cancer. N Engl J Med 1975; 293: 1164-1168.
3. Antunes CMF, Stolley PD, Rosenstein NB, et al. Endometrial cancer and estrogen use. N Engl J Med 1979; 300: 9-13.
4. Mack TM, Pike MC, Henderson BE, et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1264-1267.
5. Sturdee DW, Wade-Evans T, Paterson MEL, et al. Relations between bleeding pattern, endometrial histology and oestrogen treatment in menopausal women. BMJ 1978; 1: 1575-1577.
6. Gambrell RD, Massey FM, Castaneda TA, et al. Reduced incidence of endometrial cancer among post-menopausal women treated with progestogens. Am Geriatric Soc 1979; 27: 389-394.
7. Ferenczy A, Gelfand M, Tzipris F. The cyto-dynamics of endometrial hyperplasia and carcinoma: a review. Ann Pathol 1983; 3: 189-198.
8. Speroff L, Glass RH, Kase NG. The ovary from conception to senescence. In: Clinical Gynecological Endocrinology and Infertility. Chapter 4. Baltimore: Williams and Wilkins, 1989.
9. Highlights from an interview with Dr. John Lee. Partners Magazine (AIM International) 2001; 1-3.
10. Lee JR. What your doctor may not tell you about menopause. Transcript of a lecture given by Dr Lee in 2002. Available at: allonhealth.com/natural-progesterone/lee-menopause.htm (accessed Jan 2005).
11. Lee JR. Osteoporosis reversal with transdermal progesterone [letter]. Lancet 1990; 336: 1327.
12. Lee JR. Use of Pro-Gest cream in post-menopausal women [letter]. Lancet 1998; 352: 905.
13. Lee JR, editor. What your doctor may not tell you about menopause. New York: Warner Books, 1996.
14. Cooper A, Spencer C, Whitehead MI, et al. Systemic absorption of progesterone from Progest Cream in menopausal women [letter]. Lancet 1998; 351: 1255-1256.
15. Wren BG. Progesterone creams: do they work? [editorial]. Climacteric 2003; 6: 184-187.
16. Stevenson JC, Purdie DW. Use of Pro-Gest cream in postmenopausal women [letter]. Lancet 1998; 352: 905-906.
17. Lewis JG, McGill H, Patton VM, Elder PA. Caution on the use of saliva to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas 2002; 41: 1-6.
18. Devenuto F, Ligon D, Friedrichsen D, et al. Human erythrocyte membrane: uptake of progesterone and alterations. Biochim Biophys Acta 1969; 193: 36-47.
19. Koefoed P, Brahm J. The permeability of the human red cell membrane to steroid sex hormones. Biochim Biophys Acta 1994; 1195: 55-62.
20. Lee JR. Topical progesterone [letter]. Menopause 2003; 10: 374-377.
21. Leonetti HB, Longo S, Anasti JM. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225-228.
22. Burry KA, Patton PE, Hermsmayer K. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol 1999; 180: 1504-1511.
23. Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000; 3: 155-160.
24. Carey BJ, Carey AH, Patel S, et al. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women. BJOG 2000; 107: 722-726.
25. Leonetti H, Wilson KJ, Anasti JN. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium [letter]. Fertil Steril 2003; 79: 221-222.
26. Wren BG, Champion SM, Willets K, et al. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, mood, and quality of life for postmenopausal women. Menopause 2003; 10: 13-18.
27. Ferrero S, Gerbaldo D, Fulcheri E, Cristoforoni P. Vaginal micronised progesterone in continuous hormone replacement therapy. A prospective randomized study. Minerva Ginecol 2000; 54: 519-530.
28. Artini PG, Volpe A, Angioni S, et al. A comparative, randomized study of three different progestin support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995; 18: 51-56.
29. Elkind-Hirsch KE, Phillips K, Bello SM, et al. Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women. Hum Reprod 2002; 17: 295-298.
30. Nappi C, Affinito P, DiCarlo C, et al. Double blind controlled trial of progesterone vaginal cream treatment for cyclic mastodynia in women with benign breast disease. J Endocrinol Invest 1995; 15: 801-806.
31. McFayden IJ, Raab GM, MacIntyre CC, Forrest AP. Progesterone cream for cyclic breast pain. BMJ 1989; 298: 931.
32. Chang K-J, Lee TTY, Linares-Cruz G, et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cells in vivo. Fertil Steril 1995; 63: 785-791.